Back to results
US 9,308,213 B2Granted
Solid solution compositions and use in chronic inflammation
AssigneeInfirst Healthcare Limited
InventorsRobin M. Bannister, John Brew, Richard R. Reiley, III, Wilson Caparros Wanderley
Life of this patent
Estimating the term…
Abstract
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
Claims26
A solid solution pharmaceutical composition comprising:
- a) one or more non-steroidal anti-inflammatory drugs (NSAIDs) in an amount of about 20% to about 40% by weight of the pharmaceutical composition;
- b) one or more pharmaceutically-acceptable hard fats in an amount of at least 30% by weight of the pharmaceutical composition;
- c) one or more pharmaceutically-acceptable monoglycerides or acetylated monoglycerides that is liquid at room temperature in an amount of less than 30% by weight of the pharmaceutical composition,
- wherein the solid solution pharmaceutical composition is formulated to be a solid at a temperature of about 15° C. or lower.
1 more element
Dependencies are inferred from the claim text.